Cosentyx sensoready 150 MG penml
Ended Awarded Last action
- Contract number
- SPE2DR26F1R09
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,722
Award facts
- Contract value 100% obligated
- $23,722.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,722.05 delivery order to AmerisourceBergen Drug Corp for Cosentyx Sensoready 150 mg pens on December 22, 2025, with completion scheduled for December 23, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Cosentyx is a biologic medication used to treat inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis, reflecting the pharmaceutical distributor's role in supplying specialized brand-name medications to support military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company's comprehensive contract portfolio with DLA demonstrates its capability to deliver an extensive range of pharmaceutical products, medical devices, and healthcare supplies across multiple therapeutic domains through competitively awarded contracts. This delivery order exemplifies the company's ongoing role in the federal pharmaceutical supply chain, enabling the distribution of specialty medications necessary for maintaining military personnel and beneficiary healthcare across global operations.
Quick answers
Who was awarded contract SPE2DR26F1R09?
SPE2DR26F1R09 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F1R09 worth?
The government has obligated $23,722 on SPE2DR26F1R09.
Is contract SPE2DR26F1R09 an order under another contract?
Yes. SPE2DR26F1R09 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1R09 competed?
The extent of competition for SPE2DR26F1R09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award